“Understanding the determinants of risk and prognosis of molecular breast cancer subtypes”.
Breast CAncer STratification

About B-CAST

Breast cancer is not one entity, but different subtypes have different aetiologies and very different prognosis, ranging from highly fatal to fully curable cancers. In B-CAST tools will be developed to allow precise identification of the individual risk of breast cancer, the subtype of cancer that is most likely to develop and the prognosis of that particular subtype. This is important because the effectiveness of different preventive and early detection strategies varies by subtype, and subtypes vary in their prognosis and response to treatment. Of particular relevance is the identification of women at elevated risk of developing cancers that are most likely to be prevented by endocrine therapies, cancers that are likely to be missed by mammography screening (i.e. interval cancers), and fatal cancers.

To achieve this, within the B-CAST project existing resources, infrastructure and collaborations, established through the Breast Cancer Association Consortium (BCAC), will be exploited. Specifically, clinical information from ~80,000 breast cancer patients with risk factor information will be collated and new data on molecular characterisation of a subset of ~20,000 tumours from a unique worldwide collection from large-scale epidemiological studies, clinical studies and biobanks will be generated. Generating new genomic information based on IHC/ISH panels on ~20,000 tumours and targeted sequencing on a subset of ~10,000 tumours will inform risk and prognosis modelling of breast cancer. These models will help improve the existing online tools for risk and prognosis estimations to be used in clinical practice.


B-CAST Gene panel

A gene panel for the targeted sequencing of ~10,000 tumour samples within B-CAST has been developed. The list of 107 genes is now available.

Read more »

Kick-off symposium B-CAST & BRIDGES

The kick-off meeting was organised on 16 until 18 September2015, at the Netherlands Cancer Institute in Amsterdam. The meeting was held in collaboration with the BRIDGES consortium, because B-CAST will closely work together with this H2020 project.

Read more »


Netherlands Cancer Institute

Visiting address
Plesmanlaan 121
1066 CX Amsterdam

Postal address
Postbus 90203
1006 BE Amsterdam

+31 20 512 9111